UK Guidelines Adverse Effect on Medicinal Cannabis
Cannaweek - Cannabis Intelligence
English - September 04, 2020 12:00 - 38 minutes - 35 MBNews Commentary News Business News cannabis news cannabis industry cannabis start up cannabis market business intelligence government business analytics global cannabis research analytics cannabis Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Transitioning From the Illicit Market (Mitch Baruchowitz): Part 2
Next Episode: European Hemp and CBD in Peril (Lorenza Romanese)
Host Heather Wicklein talks with Nick Pateras, Managing Director for Europe at Materia Ventures and CKO of New Frontier Data, John Kagia. They discuss recent challenges to the NHS's interpretation of medical Cannabis' efficacy. They explore how the National Institute for Health and Care Excellence (NICE) failure to recommend Cannabis as a viable treatment has led to nearly no prescriptions being offered by the UK's doctors. The also discuss the recent push for adult-use legalization amid budgeting shortfalls in the UK's government.
Contact: [email protected]